The effects of tramadol on pain relief, fast EEG-power spectrum and cognitive function in elderly patients with chronic osteoarthritis (OA)

Acute Pain

Volumn 8, Issue 2, 2006, Pages 55-61

  Freye, E ^a   Levy, J V ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Cognitive function testing (SCAG); Elderly; Electroencephalogram; Osteoarthritis; Pain; Tramadol

Indexed keywords

TRAMADOL;

AGED; ANALGESIA; ARTICLE; BLOOD PRESSURE MONITORING; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; COXITIS; DEPRESSION; DISABILITY; DISEASE SEVERITY; DRUG EFFECT; ELBOW DISEASE; ELECTROENCEPHALOGRAM; FEMALE; GERIATRICS; HEART RATE; HUMAN; KNEE ARTHRITIS; MALE; MOOD; OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; VISUAL ANALOG SCALE;

EID: 33745676818     PISSN: 13660071     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acpain.2006.03.001     Document Type: Article

References (49)

1. Griffin M.R., Piper J.M., Dougherty J.R., Snowden M., and Ray W.A. Nonsteroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114 (1991) 257-263
2. Armstrong C.P., and Blower A.L. Non-steroidal anti-inflanmmatory drugs and life-threatening complications of peptic ulceration. Gut 28 (1987) 527-532
3. Scott L.S., and Lamb H.M. Refecoxib. Drugs 58 (1999) 499-505
4. Fröhlich C.J. NSAID: can renal side effects be avoided?. In: Vane J.R., Botting J.H., and Botting R.M. (Eds). Improved non-steroid anti-inflammatory drugs: COX-2 enzyme inhibition (1996), Kluwer Academic, Dordrecht, Boston, London 203-228
5. Brater D.C. Effects of non-steroidal antiinflammtory drugs on renal function: focus on cyclooxygenase-2 selective inhibition. Am J Med 107 (1999) 65S-71S
6. Graham D.J., Campen D., Hui R., Spence M., Cheetham C., Levy G., et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365 (2005) 475-481
7. Francis J., Serong S., Martin D., and Kapoor W. Delirium in elderly medical patients: common but often unrecognized. Clin Res 36 (1988) 711A
8. Levkoff S.E., Bresdine R.W., and Wetle T. Acute confusion states (delirium) in the hospitalized elderly. Ann Rev Gerontol Geriatr 6 (1986) 1-16
9. Parikh S.S., and Chung F. Postoperative delirium in the elderly. Anesth Analg 80 (1995) 1223-1232
10. Singelton M.A., Rosen J.I., and Fischer D.M. Pharmacokinetics of fentanyl in the elderly. Br J Anaesth 60 (1988) 619-622
11. Shimp L.A. Saftey issues in the pharmacologic mangement of chronic pain in th elderly. Pharmacotherapy 19 (1998) 1313-1322
12. Portenoy R.K. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 11 (1996) 203-217
13. Ferrell B.A., Ferrell B.R., and Rivera L. Pain in cognitively impaired nursing home patients. J Pain Symptom Manage 10 (1995) 591-598
14. Portenoy R.K. Pain management in the older cancer patient. Oncology 6 (1992) 86-98
15. Raffa R.B., and Friedrichs E. The basic science aspect of tramadol hydrochloride. Pain Rev 3 (1996) 249-271
16. Moore R.A., and McQuay H.J. Single-patient data meta-analysis of 3453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain 69 (1997) 287-294
17. Liu Z.M., Zhou W.H., Lian Z., Mu Y., Ren Z.H., Cao J.D., et al. Drug dependence and abuse potential of tramadol. Acta Pharamacol Sin 20 (1999) 52-54
18. Osipova N.A., Novikov G.A., and Beresnev V.A. Analgesic effect of tramadol in cancer patients with chronic pain: a comparison with prolonged-action morphine sulfate. Curr Ther Res Clin Exp 50 (1991) 812-821
19. Budd K. Tramadol-a step towards the ideal analgesic?. Eur J Palliat Care 2 (1995) 56-60
20. Driesen B., and Reimann W. Interaction of the central analgesic tramadol with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 105 (1992) 147-151
21. Raffa R.B., Friedrichs S., Reiman W., Shank R.P., Codd E.E., and Vaught J.L. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an "atypical" opioid analgesic. J Pharmacol Exp Ther 260 1 (1992) 275-285
22. Shader R.I., Harmatz J.S., and Salzmann C. A new scale for clinical assessement on geriatric populations: SANDOz Clnical Assesment Geriatric (SCAG). J Am Geriatr Soc 22 (1974) 107-113
23. Haitz C.M., Varner R.V., and Overall J.E. Pharmacotherapy for organic brain syndrome in late life. Arch Gen Psychiatr 34 (1977) 839-845
24. Shader R.I., Harmatz J.S., and Tammerk H.A. Towards an observational structure for rating dysfunction and pathology in ambulatory geriatrics. Topic Geront 15 (1979) 153-168
25. Venn R.D. Clinical pharmacology of ergot alkaloids in senile cerebral insufficiency. Handbook of experimental pharmacology, vol. 49 (1978), Springer, Berlin, Heidelberg, New York
26. Francis P.T., Palmer A.N., Snape M., and Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatr 66 (1999) 137-147
27. Freye E., von Bredow G., and Latasch L. Tramadol in acute treatment of migraine without aura. Dolor 13 Suppl. III (1998) 19
28. Baranauskas G., and Nistri A. Sensitization of pain pathways in the spinal cord: cellular mechanism. Prog Neurobiol 54 (1998) 349-365
29. Inouye S.K. The dilemma of dilirium: clinical and resarch controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 97 (1993) 278-288
30. Marcus D.A. Treatment of nonmalignant chronic pain. Am Fam Physician 61 (2000) 1331-1338
31. Kayser V., Besson J.M., and Guilbaud G. Evidene for noradrenergic components in the antinociceptive effect of the analgesic tramadol in an animal model of clinical pain, the arthritic rat. Eur J Pharmacol 224 (1992) 83-88
32. Raffa R.B., Friedrichs E., Reiman W., Shank R.S., Codd E.E., Vaught J.L., et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 267 (1993) 331-340
33. Bruno J.P., and Sarter M. Aminergic transmitter systems in cognitive dysfuntion. In: D'Haenen H., den Boer J.A., and Willner P. (Eds). Biological psychaitry (2002), Miley, New York, Chichester, Brisbane 3-55
34. Hennies H.H., Friedrichs H.H., Wilsmann K., and Flohè L. Effect of the opioid analgesic tramadol on inactivation of norepinephrine and serotonin. Biochem Pharmacol 31 (1982) 654-655
35. Reimann W., and Hennies H.H. Inhibition of spinal nordrenaline uptake in rats by the centrally acting analgesic tramadol. Biochem Pharmacol 47 (1994) 2289-2293
36. Bente D. Vigilanzregulation, hirnorganisches Psychosyndrom und Alterserkrankungen: Vigilanz und hirnelektrische Organisation. In: Bente D., Koper H., and Konowski S. (Eds). Hirnorganische Psychosyndrome im Alter (1982), Springer, Berlin, Heidelberg, New York 63-73
37. Bamigbade M.P., Gayles R., Foster J.M.G., and Langford R.M. Does tramadol lighten anaesthetic depth during isoflurane anaesthesia?. 8th World Congress on Pain (1996), IASP Press, Seattle, Vancouver, Canada 261
38. Coetzee J.F., Maritz J.S., and Du Toit J.C. Effect of tramadol on depth of anaesthesia. Br J Anaesth 76 (1996) 415-418
39. Freye E., Latasch L., and von Bredow G. Tramadol, opioid with nonopioid porperties, does not depress SEP in the canine as alfentanil does. Anesth Analg 84 (1997) S485
40. Richter W., Barth H., Flohè L., and Giertz H. Klinische Untersuchung zur Abhängigkeitsentwicklung bei oraler Therapie mit Tramadol. Arzneim Forsch/Drug Res 11 (1985) 1742-1744
41. Preston K.L., Jasinski D.R., and Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 27 (1991) 7-17
42. Miranda H.F., and Pinardi G. Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharmaol Biochem Behav 61 (1998) 357-360
43. Barth H., Durra S., Giertz H., Goroll D., and Flohè L. Long-term administration of the centrally acting analgesic tramadol did not induce dependence or tolerance. Pain 4 (1987) S231
44. Vickers M.D., O'Flaherty D., Szekely S.M., Read M., and Yohizumi J. Tramadol: pain relief by an opioid without respiratory depression. Anaesthesia 47 (1992) 291-296
45. Houmes R.J.M., Vorets M.A., Verkaalk A., Erdmann W., and Lachmann B. Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regard to respiratory depression. Anesth Analg 74 (1992) 510-514
46. Freye E., Rosenkranz B., and Neruda B. Die obstipierende Wirkung der Opioide Tilidin-N und Tramadol im Vergleich zu Codein. Eine vergleichende Gegenüberstellung zweier Wirkstoffkonzentrationen bei Probanden. Schmerz 10 (1996) 254-260
47. Freye E., and Latasch L. Effects of tramadol and tilidine/naloxone on oral-caecal transit and pupillary light reflex. Arzneim Forsch/Drug Res 50 (2000) 24-30
48. Lai J., Wa S.W., Porreca F., and Raffa R.B. Tramadol, M1 metabolite and enantiomers for cloned human opioid receptors expressed in tranfected HN9.10 neuroblastoma cells. Eur J Pharmacol 346 (1996) 369-372
49. Desmeules J.A., Piguet V., Collart L., and Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Phramacol 41 (1996) 7-12